Brainstorm Cell Therapeutics Inc. (BCLI)
NASDAQ: BCLI · Real-Time Price · USD
1.230
-0.030 (-2.36%)
Nov 21, 2024, 12:29 PM EST - Market open
BCLI Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 7 | 13 | 60 | 145 | 143 | 97 | |
| Market Cap Growth | 103.86% | -77.69% | -58.70% | 1.59% | 47.63% | 31.62% | |
| Enterprise Value | 7 | 15 | 57 | 123 | 116 | 97 | |
| Last Close Price | 1.26 | 4.09 | 24.60 | 60.00 | 67.87 | 64.20 | |
| PB Ratio | -3.03 | -2.75 | -19.88 | 7.50 | 4.03 | -7.92 | |
| P/TBV Ratio | - | - | - | 7.51 | 4.03 | - | |
| Debt / Equity Ratio | -0.14 | -0.26 | -1.36 | 0.26 | 0.20 | -0.19 | |
| Quick Ratio | 0.03 | 0.17 | 0.35 | 3.51 | 3.76 | 0.17 | |
| Current Ratio | 0.05 | 0.24 | 0.35 | 3.69 | 3.85 | 0.19 | |
| Return on Equity (ROE) | - | - | -297.38% | -89.25% | -273.75% | - | |
| Return on Assets (ROA) | -215.84% | -211.70% | -82.24% | -38.09% | -68.53% | -161.87% | |
| Return on Capital (ROIC) | - | - | -121.68% | -45.71% | -120.66% | - | |
| Earnings Yield | -215.86% | -128.57% | -40.51% | -16.85% | -22.27% | -24.03% | |
| FCF Yield | -172.16% | -153.13% | -32.29% | -18.33% | -24.90% | -12.11% | |
| Buyback Yield / Dilution | -69.79% | -17.99% | -0.90% | -21.22% | -36.25% | -9.54% | |
| Total Shareholder Return | -69.79% | -17.99% | -0.90% | -21.22% | -36.25% | -9.54% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.